Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES GSK PHARMA ALKEM LABORATORIES/
GSK PHARMA
 
P/E (TTM) x 33.0 57.5 57.4% View Chart
P/BV x 4.3 8.5 50.4% View Chart
Dividend Yield % 1.1 6.7 16.3%  

Financials

 ALKEM LABORATORIES   GSK PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
GSK PHARMA
Mar-22
ALKEM LABORATORIES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs4,0681,917 212.2%   
Low Rs2,6711,400 190.8%   
Sales per share (Unadj.) Rs889.4193.5 459.6%  
Earnings per share (Unadj.) Rs140.522.5 625.2%  
Cash flow per share (Unadj.) Rs166.026.5 626.2%  
Dividends per share (Unadj.) Rs34.0090.00 37.8%  
Avg Dividend yield %1.05.4 18.6%  
Book value per share (Unadj.) Rs722.4157.2 459.5%  
Shares outstanding (eoy) m119.57169.41 70.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.88.6 44.2%   
Avg P/E ratio x24.073.8 32.5%  
P/CF ratio (eoy) x20.362.6 32.4%  
Price / Book Value ratio x4.710.6 44.2%  
Dividend payout %24.2400.4 6.0%   
Avg Mkt Cap Rs m402,868280,960 143.4%   
No. of employees `000NANA-   
Total wages/salary Rs m19,6276,102 321.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,34232,780 324.4%  
Other income Rs m1,627758 214.6%   
Total revenues Rs m107,96833,538 321.9%   
Gross profit Rs m20,3807,735 263.5%  
Depreciation Rs m3,040682 445.8%   
Interest Rs m52420 2,623.7%   
Profit before tax Rs m18,4437,790 236.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6403,983 41.2%   
Profit after tax Rs m16,8033,808 441.3%  
Gross profit margin %19.223.6 81.2%  
Effective tax rate %8.951.1 17.4%   
Net profit margin %15.811.6 136.0%  
BALANCE SHEET DATA
Current assets Rs m84,35437,080 227.5%   
Current liabilities Rs m48,05316,984 282.9%   
Net working cap to sales %34.161.3 55.7%  
Current ratio x1.82.2 80.4%  
Inventory Days Days4291 46.1%  
Debtors Days Days65229 28.3%  
Net fixed assets Rs m43,2458,121 532.5%   
Share capital Rs m2391,694 14.1%   
"Free" reserves Rs m86,13424,936 345.4%   
Net worth Rs m86,37326,630 324.4%   
Long term debt Rs m940-   
Total assets Rs m127,59945,201 282.3%  
Interest coverage x36.2391.3 9.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.7 114.9%   
Return on assets %13.68.5 160.4%  
Return on equity %19.514.3 136.1%  
Return on capital %21.929.3 74.8%  
Exports to sales %18.70-   
Imports to sales %027.0 0.0%   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNA8,853 0.0%   
Fx inflow Rs m19,924528 3,775.0%   
Fx outflow Rs m3,9118,853 44.2%   
Net fx Rs m16,013-8,325 -192.4%   
CASH FLOW
From Operations Rs m11,1108,107 137.0%  
From Investments Rs m-14,351-4,055 353.9%  
From Financial Activity Rs m3,796-5,242 -72.4%  
Net Cashflow Rs m580-1,190 -48.7%  

Share Holding

Indian Promoters % 57.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 20.2 12.7 158.9%  
FIIs % 4.5 2.2 205.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 25.0 171.4%  
Shareholders   79,721 116,651 68.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ALKEM LABORATORIES vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs GSK Pharma Share Price Performance

Period ALKEM LABORATORIES GSK Pharma S&P BSE HEALTHCARE
1-Day 0.31% -0.38% -0.89%
1-Month -3.08% -0.27% -1.85%
1-Year -10.35% -27.63% -6.83%
3-Year CAGR 13.99% -6.16% 20.56%
5-Year CAGR 7.11% -11.52% 10.73%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

NTPC to Build Nuclear Fleet | Inox Group's Big Fundraise to Pare Debt | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets extended gains during the last hour of trade to end higher.